Summary of Purpose
The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments [NR2-peptide] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.Read More →
The following dates are available for this trial. Trial information last updated on 22 June 2011.
|1 Jun 2009||9 Jun 2009||1 Jun 2011||1 Jun 2011||1 Jun 2011||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case-Only
- Perspective: Prospective
- Sampling: Probability Sample